33939165|t|Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease.
33939165|a|Alzheimer's disease (AD) is the most common cause of dementia, which affects more than 5 million individuals in the USA. Unfortunately, no effective therapies are currently available to prevent development of AD or to halt progression of the disease. It has been proposed that monoacylglycerol lipase (MAGL), the key enzyme degrading the endocannabinoid 2-arachidonoylglycerol (2-AG) in the brain, is a therapeutic target for AD based on the studies using the APP transgenic models of AD. While inhibition of 2-AG metabolism mitigates beta-amyloid (Abeta) neuropathology, it is still not clear whether inactivation of MAGL alleviates tauopathies as accumulation and deposition of intracellular hyperphosphorylated tau protein are the neuropathological hallmark of AD. Here we show that JZL184, a potent MAGL inhibitor, significantly reduced proinflammatory cytokines, astrogliosis, phosphorylated GSK3beta and tau, cleaved caspase-3, and phosphorylated NF-kB while it elevated PPARgamma in P301S/PS19 mice, a tau mouse model of AD. Importantly, tau transgenic mice treated with JZL184 displayed improvements in spatial learning and memory retention. In addition, inactivation of MAGL ameliorates deteriorations in expression of synaptic proteins in P301S/PS19 mice. Our results provide further evidence that MAGL is a promising therapeutic target for AD.
33939165	14	36	2-Arachidonoylglycerol	Chemical	MESH:C094503
33939165	115	120	Mouse	Species	10090
33939165	130	149	Alzheimer's Disease	Disease	MESH:D000544
33939165	151	170	Alzheimer's disease	Disease	MESH:D000544
33939165	172	174	AD	Disease	MESH:D000544
33939165	204	212	dementia	Disease	MESH:D003704
33939165	360	362	AD	Disease	MESH:D000544
33939165	428	451	monoacylglycerol lipase	Gene	23945
33939165	453	457	MAGL	Gene	23945
33939165	489	504	endocannabinoid	Chemical	MESH:D063388
33939165	505	527	2-arachidonoylglycerol	Chemical	MESH:C094503
33939165	529	533	2-AG	Chemical	MESH:C094503
33939165	577	579	AD	Disease	MESH:D000544
33939165	636	638	AD	Disease	MESH:D000544
33939165	660	664	2-AG	Chemical	MESH:C094503
33939165	700	705	Abeta	Gene	11820
33939165	769	773	MAGL	Gene	23945
33939165	785	796	tauopathies	Disease	MESH:D024801
33939165	915	917	AD	Disease	MESH:D000544
33939165	937	943	JZL184	Chemical	MESH:C534333
33939165	954	958	MAGL	Gene	23945
33939165	1019	1031	astrogliosis	Disease	MESH:D005911
33939165	1048	1056	GSK3beta	Gene	56637
33939165	1074	1083	caspase-3	Gene	12367
33939165	1128	1137	PPARgamma	Gene	19016
33939165	1141	1146	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:19016;CorrespondingGene:5468;CorrespondingSpecies:10090
33939165	1147	1151	PS19	CellLine	CVCL:9225
33939165	1152	1156	mice	Species	10090
33939165	1164	1169	mouse	Species	10090
33939165	1179	1181	AD	Disease	MESH:D000544
33939165	1211	1215	mice	Species	10090
33939165	1229	1235	JZL184	Chemical	MESH:C534333
33939165	1330	1334	MAGL	Gene	23945
33939165	1400	1405	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;OriginalGene:19016;CorrespondingGene:5468;CorrespondingSpecies:10090
33939165	1411	1415	mice	Species	10090
33939165	1459	1463	MAGL	Gene	23945
33939165	1502	1504	AD	Disease	MESH:D000544
33939165	Association	MESH:D000544	23945
33939165	Association	MESH:C094503	11820
33939165	Negative_Correlation	MESH:C534333	56637
33939165	Negative_Correlation	MESH:C534333	MESH:D005911
33939165	Association	MESH:D063388	MESH:D000544
33939165	Association	MESH:C094503	23945
33939165	Association	MESH:D000544	HGVS:p.P301S;CorrespondingGene:5468
33939165	Negative_Correlation	MESH:C534333	12367
33939165	Negative_Correlation	MESH:C534333	23945
33939165	Positive_Correlation	MESH:C534333	19016
33939165	Association	MESH:D063388	23945
33939165	Association	MESH:C094503	MESH:D000544
33939165	Association	MESH:D000544	5468

